南方发展草畜业的几点思考

世界农业由子实体向营养体的转型、北方休牧还草政策的出台以及南方理想的自然条件和市场空间,为草畜业发展提供了千载难逢的机遇;南方发展草畜业不失为一条帮助农民快速致富的有效途径;只要破解观念更新、资金筹措、技术传授三大难题,草畜业定能成为南方农业的主要板块。     

广元市多花黑麦草品比试验

对8个多花黑麦草品种从生育期、产草量、茎叶比等方面进行了比较研究，结果表明：特高多花黑麦草l产量最高，其干物质产量为19397kg／hm^2；蓝天堂产量次之，其干物质产量为18242kg/hm^2；特优多花黑麦草产量最低，其干物质产量为14770kg/hm^2。从总体上来看，各个品种之间产量有一定的差异，但是产量差异不显著。     

分子生物学技术在弓形虫病诊断中应用的研究进展

综述了限制性片段长度多态性技术（RFLP）在刚地弓形虫虫株分类方面的应用情况,从PCR、DNA探针技术和基因重组技术方面介绍了用于检测弓形虫DNA的分子生物学技术的研究进展,叙述了编码弓形虫主要蛋白基因的克隆及其表达产物在ELISA诊断中的应用。     

副溶血弧菌基因分型和检测的研究进展

副溶血弧菌（Vibrio Parabaemolyticus，VP）是一种革兰氏阴性嗜盐杆菌，是引起食源性疾病的重要病原之一，可导致患者腹泻、肠痉挛、恶心、呕吐、发烧等典型胃肠炎反应。1998年以来的资料显示，副溶血弧菌引发的食物中毒的发生规模及人群暴露规模呈明显上升趋势，均已超过沙门氏菌食物中毒，跃居首位。为了便于进行临床诊断、流行病学调查、食品中微生物检测及医院感染监控，微生物的分型与诊断技术是必不可少的工具。随着分子生物学技术的发展，基因分型与诊断方法以其敏感性高、特异性强、分型率和分辨率佳的优点，逐渐取代传统的表型分型技术，在微生物的分型与诊断中发挥巨大的作用。本文就近年来国内外在副溶血弧菌的基因分型与检测方法上的研究作一综述。     

Iodoacetamide attenuates cognition impairment and amyloid deposit in an AD rat model

AIM:To investigate the effect of an insulin-degrading enzyme (IDE) activator, iodoacetamide, on an AD rat model. METHODS:Thirty-two male Wistar rats were divided into 4 groups:Aβ group, Aβ+ iodoacetamide group, iodoacetamide group and control. Each group included 8 subjects. Aβ was injected into the CA3 area of bilateral hippocampi;Iodoacetamide was administered subcutaneously daily for 5 consecutive days before surgery. The behavior performance in the morris water maze was obtained. The level of Aβ was detected by immunohistochemistry staining and ELISA assay. RESULTS:Level of Aβ was significantly reduced in Aβ+iodoacetamide group compared with that of Aβ group (dropped by 24%), and the Aβ deposit decreased (by 23.9%), the cognition function of this group also greatly improved according to the behavior performance in the morris water maze. The mean escape latency in the place navigation was much lower compared to Aβ group and the times that rats acrossed the central platform in the spatial probe test was also elevated. CONCLUSION:Iodoacetamide significantly reduces the Aβ deposit in the hippocampus in an AD rat model and relieves memory loss.     

果梅花不同发育阶段花粉原位萌发及花粉管生长特性

为探明自花、异花花粉在果梅花的不同发育阶段原位萌发及生长的特性,以细叶青果梅为材料,取开花前6、4、2d、开花当天和花后2d的花(花蕾),分别于自花、异花授粉(莺宿)后12、24、48、72、96h切取花柱,用FAA固定液处理,荧光染色后压片观察。结果表明,自花花粉在柱头上的萌发率略低于异花(开花前4d存在显著差异),开花前6、4d极显著低于其他各阶段,花蕾越幼小花粉萌发越差,开花当天花粉萌发率超过80%;开花前4d之前的花柱内异花花粉管数量显著低于开花前2d及之后各期的,果梅开花前4d以前的花发育不充分;开花后2d生长到花柱基部的异花花粉管数量较多,属于有效授粉期。果梅在开花前4d开始具备抑制自花花粉管生长的能力,并且随着花的发育逐渐增强,开花当天最强,开花后开始减弱。果梅自交授粉期以开花前2～3d为宜。     

应用轻型飞机防治马尾松毛虫的试验Ⅰ．喷施四种药剂防治的效果

马尾松毛虫Dendrolimus punctatus Walker是马尾松林重要害虫。林间应用超轻型飞机大面积喷洒溴氰菊酯超低容量喷雾、白僵菌纯孢子油剂、菌药混合液超低容量喷雾以及喷洒白僵菌菌粉,其防治效果分别为96．5%、85．7%、95．6%、86．5%。上述的防治措施可作为单独的措施或综合防控中的配套措施使用,同时应用飞机防治解决了树高、林密、水源缺乏、劳力工资昂贵等条件给防治工作带来的困难,是一种适应林区林业生产整体水平而又快速、高效、经济的防治手段。     

气相色谱法测定咸鱼中的敌百虫和敌敌畏

建立了咸鱼中敌百虫、敌敌畏农药残留的气相色谱分析方法。样品采用乙腈-水(1 1)溶液提取,加乙酸锌净化,用乙酸乙酯进行液液分配,最后采用DB-1701P或DB-5毛细管柱分离,使用气相色谱-火焰光度检测器分析。在4个添加水平的敌百虫、敌敌畏平均回收率(n=6)分别为91%~95%、90%~94.5%,相对标准偏差分别为3.82%~5.80%和3.57%~4.62%;方法的检出限为:敌百虫0.005 mg/kg,敌敌畏0.005 mg/kg。该方法可用于市场上咸鱼样品中敌百虫、敌敌畏的测定。     

Influences of coculture with bone marrow mesenchymal stem cells on dopaminergic neurons in brain slice treated with 1-methyl-4-phenylpytidinium

AIM: To study the protective effects of bone marrow-derived mesenchymal stem cells on damaged dopaminergic neurons induced by 1-methyl-4-phenylpytidinium(MPP+).METHODS: The parkinson disease(PD) models were established in newborn rats. Bone marrow mesenchymal stem cells(MSCs) obtained from adult bone marrow were cultured, isolated and purified. MSCs were co-cultured with brain slice and the immunohistochemical technique, electron microscopy, propidium iodide staining were used to observe the changes of neurons. RESULTS: In the MPP+ treatment group, the neurites grew slowly and sparsely, dead cells were found in all regions. In the co-culture group, the neuritis grew densely, only a few cells were dead, the number of tyrosine hydroxylase(TH)-stained neurons increased and the structure of organellae was normal. CONCLUSION: MSCs may protect dopaminergic neurons against damage induced by MPP+. These results provide some data for cell transplantation therapy to Parkinsons disease.